Marshall Wace North America’s CONMED CNMD Stock Holding History

Marshall Wace North America’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-16,805	Closed	-$1.21M	–	1245
2020 Q2	$1.21M	Sell	16,805 -19,152	-53%	-$1.33M	0.01%	712
2020 Q1	$2.06M	Buy	+35,957	New	+$3.32M	0.02%	475
2019 Q4	–	Sell	-525	Closed	-$50K	–	1326
2019 Q3	$50K	Sell	525 -51,589	-99%	-$4.84M	﹤0.01%	1160
2019 Q2	$4.46M	Buy	52,114 +17,593	+51%	+$1.45M	0.03%	390
2019 Q1	$2.87M	Buy	34,521 +25,182	+270%	+$1.83M	0.02%	427
2018 Q4	$600K	Buy	+9,339	New	+$639K	0.01%	737
2018 Q3	–	Sell	-44,536	Closed	-$3.26M	–	981
2018 Q2	$3.26M	Buy	44,536 +32,500	+270%	+$2.21M	0.02%	629
2018 Q1	$762K	Buy	+12,036	New	+$719K	﹤0.01%	1063

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Marshall Wace North America's CNMD Position: Q3 2020 in Review

Marshall Wace North America sold out of CONMED (CNMD) in Q3 2020, closing a stake of 16,805 shares — an estimated $1.21M sold.

Marshall Wace North America first reported a position in CNMD in Q1 2018 and held it in 8 quarters. The position peaked at $4.46M in Q2 2019. 240 funds tracked by Wall St. Rank hold CNMD as of Q3 2020.

Marshall Wace North America reported no remaining CONMED position as of Q3 2020 after selling out during the quarter.
Marshall Wace North America sold 16,805 CONMED shares in Q3 2020, an estimated $1.21M.
Marshall Wace North America first reported a position in CONMED in Q1 2018 and held it in 8 quarters.
Marshall Wace North America's CONMED position peaked at $4.46M in Q2 2019.
240 funds tracked by Wall St. Rank held CONMED as of Q3 2020.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.